• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Opmed.ai Secures $15M to Bring AI Optimization to Healthcare Operations

by Syed Hamza Sohail 05/06/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

–              Opmed.ai, the AI optimization platform for healthcare, announced today the successful raise of $15M in series A funding.

–              The round was co-led by NFX and Grove Ventures, with Secret Chord Ventures, the Impact investor Sir Ronald Cohen, and Unbox Ventures also participating

Revolutionizing Healthcare Efficiency: Opmed.ai’s AI-Powered OR Optimization Solutions

The funding announcement arrives amidst a critical shortage in healthcare labor, with projections indicating a deficit of 3.2 million healthcare professionals by 2026. Meanwhile, hospitals grapple with escalating labor costs, which surged beyond 20% last year. Operating Rooms (ORs) constitute a substantial portion, accounting for 40% of a hospital’s expenses while generating 60-70% of its revenue, often serving as the primary driver of profitability. Nonetheless, the inefficiencies in OR scheduling, facilitated through archaic spreadsheets or predominantly manual methods, compound these challenges.

Enter Opmed.ai, specializing in optimizing healthcare operations, with a primary focus on OR efficiency, leveraging advanced AI technology. The company’s optimization engine rapidly assesses billions of permutations, customized to forecast based on industry-specific variables, automatically generating alternative schedules that vastly enhance resource utilization. Considering that each idle minute potentially translates to revenue losses ranging from $50 to $150, with empty ORs incurring costs of $1,000 per unused hour, the impact of this technology is profound. By adopting Opmed.ai, hospitals stand to gain over $1 million per OR in additional revenue annually, while concurrently slashing costs by $500,000 and fortifying resilience against unforeseen disruptions.

Despite the intricate nature of ORs and healthcare environments at large, Opmed.ai boasts an implementation timeframe of merely two to four weeks. Once deployed, it identifies over and underestimations, addresses gaps, anesthesia durations, turnover times, and other pertinent factors, subsequently generating optimized alternative plans. These plans account for staffing, equipment, preferences, add-ons, and various other considerations, streamlining the process for scheduling professionals with just a few clicks. Moreover, the platform facilitates the creation of longer-term quarterly and yearly block allocation plans, driving OR utilization up by 10% and yielding compounded savings and revenue. Remarkably, the return on investment for hospitals typically materializes within a mere 3-4 months.

Founded by Dr. Mor Brokman Meltzer, Avi Paz, and Prof. Baruch Barzel, Opmed.ai presents an innovative healthcare optimization engine, harnessing AI and network science to revolutionize healthcare scheduling and resource allocation, commencing with operating rooms.

“Opmed.ai is a perfect representation of the next generation of great AI platforms. They solve a complex issue with a highly specialized vertical solution that has no alternative that comes close,” said Renana Ashkenazi, General Partner of Grove Ventures. “Adding to the attractiveness of the investment is the fact that the ROI is so clear and significant, even from an early stage. We’ve seen the millions of dollars it has saved and generated in hospitals where it’s already deployed, and as impressed as we were, the hospitals’ enthusiasm has been even greater. We look forward to helping the Opmed.ai team rapidly expand in both the hospitals and use cases they serve.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |